Sree on the Dasatinib trial at the University of Michigan
Posted: Fri Apr 29, 2011 9:30 am
Reposted from the personal updates:
"Sree is currently on the Dasatinib trial at the University of Michigan. He hasn't had any scans since starting the trial, so we don't know how it affects his tumors yet.
After coming off Cediranib, we did see significant growth in his lung mets, sutent could not stop the progression(tried it for 2 months) and he is now on dasatinib."
"Sree is currently on the Dasatinib trial at the University of Michigan. He hasn't had any scans since starting the trial, so we don't know how it affects his tumors yet.
After coming off Cediranib, we did see significant growth in his lung mets, sutent could not stop the progression(tried it for 2 months) and he is now on dasatinib."